Appointment US Based Non-Executive Director: Simon Arkell
LBT Innovations is pleased to announce the appointment of Simon Arkell as a Non-Executive Director, starting 30th January 2019.
continue readingFDA 510(k) submitted for APAS® Independence
LBT Innovations joint venture company, Clever Culture Systems submits US FDA 510(k) for APAS Independence instrument with Urine Analysis Module.
continue readingAustralian Sales Update
LBT Innovations provides an update on sales activities in the Australian market and previously advised expected sales of the APAS® Independence in calendar 2018.
continue readingFirst Placement of APAS Independence into US Lab
Clever Culture Systems has placed the first APAS® Independence into a US medical centre to act as a key opinion leader ahead of US commercial launch.
continue readingAPAS Independence wins award at MDEA
The APAS Independence, the product of Clever Culture Systems, has won Silver at the Medical Design Excellence Awards in New York.
continue readingAPAS Independence – MDEA award Finalist
The APAS Independence, the product of Clever Culture Systems, has been nominated as a finalist in the Medical Design Excellence Awards.
continue readingUsing AI to automate clinical microbiology
Australian Government grant initiative. Business.com.au Research and Development Tax Incentives - Customer Story on LBT Innovations
continue readingExtraordinary General Meeting Presentation 2018
Presentation by Brent Barnes Chief Executive Officer & Managing Director of LBT Innovations at this April's Extraordinary General Meeting
continue reading
